Control of vascular tone in notothenioid fishes is determined by phylogeny, not environmental temperature.
We examined potential vasomotor control mechanisms in an Antarctic fish (Trematomus bernacchii; usual core temperature approximately -1 degrees C), comparing sensitivity to agonists by means of the cumulative dose response and potency with reference to depolarization by 50 mM KCl. In efferent branchial arteries, norepinephrine (NE) produced approximately 20% of the maximal KCl tension and ~40% in the presence of 10(-3)M sotalol, suggesting a modest contribution of alpha- and beta-adrenergic tonus [half-maximal response (pEC(50)) = 6.29 +/- 0.37 M]. Carbachol (CBC) and serotonin (5-HT) had different sensitivities (pEC(50) = 4.50 +/- 0.40 and 6.82 +/- 0.08 M, respectively) but similar potencies (21.6 +/- 11.1 and 31.1 +/- 5.3% of KCl). A related species from warmer waters around New Zealand, Paranotothenia angustata, had similar vascular reactivity for NE (pEC(50) = 5.48 +/- 0.31 M), CBC (pEC(50) = 4.94 +/- 0.22 M), and methysergide-sensitive vasoconstriction with 5-HT (pEC(50) = 6.22 +/- 0.40 M). Agonist potencies were 9, 65, and 45% that of KCl, respectively. Bovichtus variegatus, a member of the phylogenetic sister group to the notothenioids, also gave broadly similar responses. In contrast, Dissostichus mawsoni, a pelagic Antarctic notothenioid, showed a dominance of vasodilatation over vasoconstriction, with sensitive isoprenaline (pEC(50) = 6.66 +/- 0.05 M) but weak serotonergic (5.2 +/- 1.5% KCl) responses. The unusual dominance of serotonergic control appears to be primarily a consequence of evolutionary lineage rather than low environmental temperature, but the pattern may be modified according to functional demand.
Department of Zoology, University of Canterbury, Private Bag 4800, Christchurch, New Zealand. s.egginton@bham.ac.uk
S
S
Egginton
M E
ME
Forster
W
W
Davison
D000818:Animals; D000864:Antarctic Regions; D001011:Aorta / Q000187:drug effects / Q000502:physiology; D001158:Arteries / Q000187:drug effects / Q000502:physiology*; D001285:Atropine / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D001831:Body Temperature; D001934:Branchial Region / Q000098:blood supply*; D002217:Carbachol / Q000494:pharmacology; D017753:Ecosystem; D004777:Environment; D004837:Epinephrine / Q000494:pharmacology; D006339:Heart Rate / Q000187:drug effects; D066298:In Vitro Techniques; D009119:Muscle Contraction / Q000187:drug effects*; D009129:Muscle Tonus; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000502:physiology*; D009520:New Zealand; D009638:Norepinephrine / Q000494:pharmacology; D010473:Perciformes / Q000145:classification / Q000235:genetics / Q000502:physiology*; D010802:Phylogeny; D011189:Potassium Chloride / Q000494:pharmacology; D012701:Serotonin / Q000494:pharmacology; D013015:Sotalol / Q000494:pharmacology; D013045:Species Specificity
D012701:Serotonin; D011189:Potassium Chloride; D001285:Atropine; D002217:Carbachol; D013015:Sotalol; D009638:Norepinephrine; D004837:Epinephrine